The relationship between follistatin and chronic low-grade inflammation in women with polycystic ovary syndrome

Fertility and Sterility

Volumn 92, Issue 6, 2009, Pages 2041-2044

  Chen, Mei Jou ^a,b   Chen, Hsin Fu ^a,b   Chen, Shee Uan ^a   Ho, Hong Nerng ^a   Yang, Yu Shih ^a   Yang, Wei Shiung ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

C reactive protein; follistatin; inflammation; insulin resistance; obesity; Polycystic ovary syndrome

Indexed keywords

C REACTIVE PROTEIN; FOLLISTATIN; GLUCOSE; INSULIN; INTERLEUKIN 6;

ADULT; ARTICLE; BODY MASS; CHRONIC INFLAMMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OBESITY; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROBABILITY; PROTEIN BLOOD LEVEL; STUDENT T TEST;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHRONIC DISEASE; FEMALE; FOLLISTATIN; HUMANS; INSULIN RESISTANCE; OBESITY; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 70749094391     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.06.009     Document Type: Article

References (25)

1. Bilezikjian L.M., Blount A.L., Leal A.M., Donaldson C.J., Fischer W.H., and Vale W.W. Autocrine/paracrine regulation of pituitary function by activin, inhibin and follistatin. Mol Cell Endocrinol 225 (2004) 29-36
2. Iemura S., Yamamoto T.S., Takagi C., Uchiyama H., Natsume T., Shimasaki S., et al. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci U S A 95 (1998) 9337-9342
3. Sakamoto Y., Shintani Y., Harada K., Abe M., Shitsukawa K., and Saito S. Determination of free follistatin levels in sera of normal subjects and patients with various diseases. Eur J Endocrinol 135 (1996) 345-351
4. Kumar T.R. Too many follistatins: racing inside and getting out of the cell. Endocrinology 146 (2005) 5048-5051
5. Matzuk M.M., Lu N., Vogel H., Sellheyer K., Roop D.R., and Bradley A. Multiple defects and perinatal death in mice deficient in follistatin. Nature 374 (1995) 360-363
6. Guo Q., Kumar T.R., Woodruff T., Hadsell L.A., DeMayo F.J., and Matzuk M.M. Overexpression of mouse follistatin causes reproductive defects in transgenic mice. Mol Endocrinol 12 (1998) 96-106
7. Norman R.J., Milner C.R., Groome N.P., and Robertson D.M. Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome. Hum Reprod 16 (2001) 668-672
8. Eldar-Geva T., Spitz I.M., Groome N.P., Margalioth E.J., and Homburg R. Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome. Hum Reprod 16 (2001) 2552-2556
9. Erickson G.F., Chung D.G., Sit A., DePaolo L.V., Shimasaki S., and Ling N. Follistatin concentrations in follicular fluid of normal and polycystic ovaries. Hum Reprod 10 (1995) 2120-2124
10. Klein R., Clarke I.J., Hedger M.P., and Robertson D.M. Plasma follistatin concentrations increase following lipopolysaccharide administration in sheep. Clin Exp Pharmacol Physiol 23 (1996) 754-755
11. Phillips D.J., Hedger M.P., McFarlane J.R., Klein R., Clarke I.J., Tilbrook A.J., et al. Follistatin concentrations in male sheep increase following sham castration/castration or injection of interleukin-1 beta. J Endocrinol 151 (1996) 119-124
12. Dohi T., Ejima C., Kato R., Kawamura Y.I., Kawashima R., Mizutani N., et al. Therapeutic potential of follistatin for colonic inflammation in mice. Gastroenterology 128 (2005) 411-423
13. Michel U., Schneider O., Kirchhof C., Meisel S., Smirnov A., Wiltfang J., et al. Production of follistatin in porcine endothelial cells: differential regulation by bacterial compounds and the synthetic glucocorticoid RU 28362. Endocrinology 137 (1996) 4925-4934
14. Wilson K.M., Smith A.I., and Phillips D.J. Stimulatory effects of lipopolysaccharide on endothelial cell activin and follistatin. Mol Cell Endocrinol 253 (2006) 30-35
15. Jones K.L., Mansell A., Patella S., Scott B.J., Hedger M.P., de Kretser D.M., et al. Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci U S A 104 (2007) 16239-16244
16. Chang K., Weiss D., Suo J., Vega J.D., Giddens D., Taylor W.R., et al. Bone morphogenic protein antagonists are coexpressed with bone morphogenic protein 4 in endothelial cells exposed to unstable flow in vitro in mouse aortas and in human coronary arteries: role of bone morphogenic protein antagonists in inflammation and atherosclerosis. Circulation 116 (2007) 1258-1266
17. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
18. Tarkun I., Arslan B.C., Canturk Z., Turemen E., Sahin T., and Duman C. Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. J Clin Endocrinol Metab 89 (2004) 5592-5596
19. Moran L.J., Noakes M., Clifton P.M., Wittert G.A., Belobrajdic D.P., and Norman R.J. C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome. J Clin Endocrinol Metab 92 (2007) 2944-2951
20. Boulman N., Levy Y., Leiba R., Shachar S., Linn R., Zinder O., et al. Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab 89 (2004) 2160-2165
21. Chen M.J., Yang W.S., Yang J.H., Hsiao C.K., Yang Y.S., and Ho H.N. Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS. Hum Reprod 21 (2006) 2266-2271
22. Chen M.J., Yang W.S., Yang J.H., Chen C.L., Ho H.N., and Yang Y.S. Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome. Hypertension 49 (2007) 1442-1447
23. Chen M.J., Yang W.S., Chen C.L., Wu M.Y., Yang Y.S., and Ho H.N. The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome. Hum Reprod 23 (2008) 952-957
24. Khoury R.H., Wang Q.F., Crowley Jr. W.F., Hall J.E., Schneyer A.L., Toth T., et al. Serum follistatin levels in women: evidence against an endocrine function of ovarian follistatin. J Clin Endocrinol Metab 80 (1995) 1361-1368
25. Kettel L.M., DePaolo L.V., Morales A.J., Apter D., Ling N., and Yen S.S. Circulating levels of follistatin from puberty to menopause. Fertil Steril 65 (1996) 472-476